グランダキシン（Ｔｏｆｉｓｏｐａｍ）の皮膚疾患に対する治療成績

DOI

書誌事項

タイトル別名
  • Clinical Evaluation of Grandaxin(Tofisopam) on several skin diseases.

抄録

The efficacy, safety and usefulness of tofisopam (Grandaxin®), an automatic regulating drug, were examined on several skin diseases by open trial. Grandaxin was administered in 53 patients, of whom 14 had pruritus cutaneus universalis, 7 pruritus cutaneus localis, 16 chronic urticaria, 11 hyperidrosis and 5 dyshidrotic eczema. The result rated as useful was seen in 36% of pruritus cutaneus universalis, 71% of pruritus cutaneus localis, 31% of chronic urticaria, 45% of hyperidrosis and 40% of dyshidrotic eczema.<BR>Mild side effects were seen in 2 cases (3.8%). One was staggering, and other was nausea and diarrhea, but these symptom promptly disappeared by cessation of the drug. These results indicate that tofisopam (Grandaxin®) is a useful drug for these intractable skin diseases.

収録刊行物

  • 皮膚

    皮膚 35 (1), 195-202, 1993

    日本皮膚科学会大阪地方会

キーワード

詳細情報 詳細情報について

  • CRID
    1390282679777357056
  • NII論文ID
    130004045508
  • DOI
    10.11340/skinresearch1959.35.195
  • ISSN
    1884541X
    00181390
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ